Select Medical Holdings Corporation (SEM)

Select Medical Holdings Stock Forecast

Stock Price Forecast

The 4 analysts that cover Select Medical Holdings stock have a consensus rating of "Buy" and an average price target of $27.33, which forecasts a 88.35% increase in the stock price over the next year. The lowest target is $19 and the highest is $42.

Price Target: $27.33 (+88.35%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$19	$27.33	$21	$42
Change	+30.94%	+88.35%	+44.73%	+189.46%

* Price targets were last updated on May 7, 2025.

Analyst Ratings

The average analyst rating for Select Medical Holdings stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	1	1	1	1	1	1
Buy	1	1	1	1	1	1
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ben Hendrix RBC Capital	RBC Capital	Buy Maintains $23 → $19	Buy	Maintains	$23 → $19	+30.94%	May 7, 2025
Ben Hendrix RBC Capital	RBC Capital	Buy Maintains $47 → $23	Buy	Maintains	$47 → $23	+58.51%	Feb 24, 2025
A.J. Rice UBS	UBS	Hold Maintains $40 → $21	Hold	Maintains	$40 → $21	+44.73%	Jan 3, 2025
Bill Sutherland Benchmark	Benchmark	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Nov 25, 2024
Ben Hendrix RBC Capital	RBC Capital	Buy Maintains $40 → $47	Buy	Maintains	$40 → $47	+223.91%	Nov 4, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

5.46B

Increased by 5.26%

from 5.19B

Revenue Next Year

5.75B

Increased by 5.29%

from 5.46B

EPS This Year

1.11

Decreased by -34.41%

from 1.70

EPS Next Year

1.30

Increased by 17.07%

from 1.11

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	5.53B	6.20B	4.61B	4.83B	5.19B	5.46B	5.75B	6.04B
Revenue Growth	1.43%	12.16%	-25.71%	4.70%	7.48%	5.26%	5.29%	5.08%
EPS	1.93	2.98	1.28	1.96	1.70	1.11	1.30	1.58
EPS Growth	75.01%	54.90%	-57.12%	53.18%	-13.35%	-34.41%	17.07%	21.29%
Forward PE	-	-	-	-	-	13.02	11.12	9.17
No. Analysts	-	-	-	-	-	7	7	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	5.7B	6.0B	6.4B
Avg	5.5B	5.7B	6.0B
Low	5.3B	5.5B	5.7B

Revenue Growth

Revenue Growth	2025	2026	2027
High	10.6%	10.7%	10.7%
Avg	5.3%	5.3%	5.1%
Low	1.3%	1.0%	-0.1%

EPS Forecast

EPS	2025	2026	2027
High	1.20	1.62	1.97
Avg	1.11	1.30	1.58
Low	1.04	1.18	1.37

EPS Growth

EPS Growth	2025	2026	2027
High	-29.5%	45.1%	51.3%
Avg	-34.4%	17.1%	21.3%
Low	-38.9%	5.5%	5.2%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.